Evidence map›Paper›PMID 40443591›Full record

ReviewCureus2025

Technical Considerations of Ozonated Oils in Medical Applications: A Narrative Review.

Mandala Sathwik, Satyalakshmi Komarraju, Sathyanath D, Shrikanth Muralidharan

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Identification of Bioactive Medium Chain Fatty Acids (CAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Ozone-Assisted Green Upgrading ofFoods (Basel, Switzerland) · 2025
    Article
  3. Historical Highlights of Ozone Therapy.Journal of pharmacy & bioallied sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mandala SathwikDepartment of Ozone Therapy, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, IND.
Satyalakshmi KomarrajuDepartment of Naturopathy and Yoga, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, IND.
Sathyanath DDepartment of Clinical Naturopathy, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, IND.
Shrikanth MuralidharanDepartment of Research, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozonated oils, derived from the reaction of ozone with unsaturated fatty acids in vegetable oils such as coconut, olive, sunflower, and sesame, have gained significant attention in medical applications due to their recognized germicidal, immune-stimulating, and tissue-repairing properties. These stabilized ozonated oils release ozone gradually in the form of ozonides, which are stable and capable of providing prolonged therapeutic effects, mainly when applied topically. The germicidal properties of ozonated oils, primarily exerted through the oxidation of microbial cell walls, make them effective in treating various conditions, including skin infections, dermatitis, and fungal infections. Despite ozone's inherent instability, ozonated oils have demonstrated substantial therapeutic efficacy, including bactericidal, fungicidal, and virucidal effects. The clinical use of ozonated oils is expanding, offering a lower-cost, effective alternative to conventional treatments, especially in managing infections resistant to antibiotics. While their primary application remains topical, there is growing evidence of their positive effects when used orally, particularly in enhancing immune function and promoting tissue regeneration. This review examines the technical considerations for the medical application of ozonated oils, focusing on their stability, chemical characteristics, and therapeutic potential.

Indexed as

clinical useconventional treatmentscriegee reactionozonated oilsquality control

Identifiers

PMID40443591
PMCPMC12121633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.